Panax ginseng reduces adriamycin-induced heart failure in rats

Phytotherapy Research

Volumn 19, Issue 12, 2005, Pages 1018-1022

  You, Jyh Sheng ^a,b   Huang, Hui Feng ^c   Chang, Ying Ling ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Adriamycin; Heart failure; Panax ginseng; Traditional Chinese medicine

Indexed keywords

ANTIOXIDANT; DOXORUBICIN; GINSENG EXTRACT; GLUTATHIONE PEROXIDASE; HEART ENZYME; SUPEROXIDE DISMUTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; FEEDING APPARATUS; GINSENG; HEART FAILURE; HEART PROTECTION; LIPID PEROXIDATION; LIVER CONGESTION; MACROMOLECULE; MALE; MORTALITY; NONHUMAN; PROTEIN SYNTHESIS; RAT; RNA SYNTHESIS;

ANIMALS; ANTIOXIDANTS; CARDIOMYOPATHY, DILATED; DOXORUBICIN; FREE RADICALS; LIPID PEROXIDATION; MALE; NUCLEIC ACID SYNTHESIS INHIBITORS; PANAX; PHYTOTHERAPY; PLANT EXTRACTS; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR;

ANIMALIA; PANAX GINSENG; RATTUS NORVEGICUS;

EID: 31144456169     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.1778     Document Type: Article

References (28)

1. Arena E, Biondo F, D'Alessandro N, Dusoncher L, Gebbia N, Gerbasi R. 1974. DNA, RNA and protein synthesis in heart, liver and brain of mice treated with daunorubicin or adriamycin. Int Res Commun Syst Med Sci 2: 1053-1061.
2. Block KI, Mead MN. 2003. Immune system effects of echinacea, ginseng, and astragalus: a review. Integr Cancer Ther 2: 247-267.
3. Chang MS, Lee SG, Rho HM. 1999. Transcriptional activation of Cu/Zn superoxide dismutase and catalase genes by panaxadiol ginsenosides extracted from Panax ginseng. Phytother Res 13: 641-644.
4. Gewitz DA. 1999. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem Pharmacol 57: 727-741.
5. Gosavlez MG, VanRossum DV, Blanco MF. 1979. Inhibition of sodium-potassium activated adenosine, 5-triphosphatase and non transport by adriamycin. Cancer Res 39: 257-261.
6. Jackson JA, Reeves JP, Muntx KH et al. 1984. Evaluation of free radical effects and catecholamine alterations in adriamycin cardiotoxicity. Am J Pathol 117: 140-153.
7. Kang J, Lee Y, No K et al. 2002. Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis. Reprod Toxicol 16: 291-298.
8. Kim SH, Park KS. 2003. Effects of Panax ginseng extract on lipid metabolism in humans. Pharmacol Res 48: 511-513.
9. Kitts D, Hu C. 2000. Efficacy and safety of ginseng. Public Health Nutr 3: 473-485.
10. Kitts D, Wijewickreme AN, Hu C. 2000. Antioxidant properties of a North American ginseng extract. Mol Cell Biochem. 203: 1-10.
11. Kumar D, Kirshenbaum LA, Li T, Danelisen I, Singal PK. 2001. Apoptosis in adriamycin caradiomyopathy and its modulation by probucol. Antioxid Redox Signal 3: 135-145.
12. Lin CF, Wong KL, Wu RS, Hung TC, Liu CF. 2003. Protection by hot water extract of Panax notoginseng on chronic ethanol-induced hepatotoxicity. Phytother Res 17: 1119-1122.
13. Maffei Facino R, Carini M, Aldini G, Berti F, Rossoni G. 1999. Panax Ginseng administration in the rat prevents myocardial ischemia-reperfusion damage induced by hyperbaric oxygen: evidence for an antioxidant intervention. Planta Med 65: 614-619.
14. Monti E, Prosperi E, Supino R, Bottiroli G. 1995. Free radical-dependent DNA lesions are involved in the delayed cardiotoxicity induced by adriamycin in the rat. Anticancer Res 15: 193-197.
15. Morishima I, Matsui H, Mukawa H. 1998. Melatonin, a pineal hormone with antioxidant property, protects against adriamycin cardiomyopathy in rats. Life Sci 63: 511-521.
16. Rabelo E, Angelis KDE, Bock P et al. 2001. Baroreflex sensitivity and oxidative stress in adriamycin-induced heart failure. Hypertension 38: 576-580.
17. Seifert CF, Nesser ME, Thompson DF. 1994. Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity. Ann Pharmacother 28: 1063-1072.
18. Shao ZH, Xie JT, Vanden Hoek TL et al. 2004. Antioxidant effects of American ginseng berry extract in cardiomyocytes exposed to acute oxidant stress. Biochim Biophys Acta 1670: 165-171.
19. Singal PK, Deally CMR, Weinberg LE. 1987. Subcellular effects of adriamycin in the heart: A concise review. J Mol Cell Cardiol 19: 817-828.
20. Singal PK, Iliskovic N, Li T, Kumar D. 1997. Adriamycin cardiomyopathy: pathophysiology and prevention. FASEB J 11: 931-936.
21. Singal PK, Siveski-Iliskovic N. 1998. Doxorubicin-induced cardiomypathy. N Engl J Med 339: 900-905.
22. Siveski-Iliskovic N, Kaul N, Singal PK. 1994. Probucol promotes endogenous antioxidants and provides protection against adriamycin-induced cardiomyopathy in rats. Circulation 89: 2829-2835.
23. Steinhertz LJ, Steinhertz PG, Tan CTC, Heller G, Murphy L. 1991. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. J Am Med Assoc 266: 1672-1677.
24. Tong J, Ganguly PK, Singal PK. 1991. Myocardial adrenergic changes at two stages of heart failure due to adriamycin treatment in rats. Am J Physiol 260: H909-H916.
25. Van Acker SABE, Kramer K, Voest EE et al. 1996. Doxorubicin-induced cardiotoxicity monitored by ECG in freely moving mice. Cancer Chemother Pharmacol 38: 95-101.
26. Wu S, Ko YS, Teng MS et al. 2002. Adriamycin-induced cardiomycyte and endothelial cell apoptosis: in vitro and in vivo studies. J Mol Cell Cardiol 34: 1595-1607.
27. Yoda Y, Nakazaqa M, Abe T, Kawakami Z. 1986. Prevention of doxorubicin myocardial toxicity in mice by reduced glutathione. Cancer Res 46: 2551-2556.
28. Yokozawa T, Satoh A, Cho EJ. 2004. Ginsenoside-Rd attenuates oxidative damage related to aging in senescence-accelerated mice. J Pharm Pharmacol 56: 107-113.